Cargando…
Dexmedetomidine Attenuates Neuroinflammatory–Induced Apoptosis after Traumatic Brain Injury via Nrf2 signaling pathway
OBJECTIVE: Dexmedetomidine (DEX) exhibits neuroprotective effects as a multifunctional neuroprotective agent in numerous neurological disorders. However, in traumatic brain injury (TBI), the molecular mechanisms of these neuroprotective effects remain unclear. The present study investigated whether...
Autores principales: | Li, Fayin, Wang, Xiaodong, Zhang, Zhijie, Zhang, Xianlong, Gao, Pengfei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6764501/ https://www.ncbi.nlm.nih.gov/pubmed/31478596 http://dx.doi.org/10.1002/acn3.50878 |
Ejemplares similares
-
Dexmedetomidine attenuates traumatic brain injury: action pathway and mechanisms
por: Wang, Dong, et al.
Publicado: (2018) -
The role of bioactive lipids in attenuating the neuroinflammatory cascade in traumatic brain injury
por: Poblete, Roy A., et al.
Publicado: (2020) -
Neuroinflammatory responses to traumatic brain injury
por: Paiva, Wellingson Silva, et al.
Publicado: (2015) -
Dexmedetomidine alleviates early brain injury following traumatic brain injury by inhibiting autophagy and neuroinflammation through the ROS/Nrf2 signaling pathway
por: Feng, Xiaoyan, et al.
Publicado: (2021) -
Dexmedetomidine Attenuates LPS-Induced Acute Lung Injury in Rats by Activating the Nrf2/ARE Pathway
por: Qiu, Yuandong, et al.
Publicado: (2022)